Bronchodilator Agents: all 1,999 studies that test it

Page 19 of 20. Open to participants first (185), then studies with results posted, then the rest; newest registration first within each.

• Effect of Tiotropium on Inflammation and Exacerbations in COPDCompletedNCT00405236Phase 4
• Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent ImplantationCompletedNCT00404716Phase 4
• A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00403286Phase 2
• Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone PropionateCompletedNCT00400855Phase 2
• A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUSCompletedNCT00400608Phase 4
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.CompletedNCT00398645Phase 2
• Tiotropium + Procaterol vs Tiotropium + Placebo in COPD PatientsTerminatedNCT00394485Phase 4
• New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With AsthmaCompletedNCT00394121Phase 3
• Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and MannitolCompletedNCT00390624Phase 2
• Follow-Up at 6 Years of a Cohort of Children Born Very PrematurelyCompletedNCT00390065Phase 4
• Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.CompletedNCT00388882Phase 4
• Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency DepartmentWithdrawnNCT00388739Not applicable
• A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath ControlStatus unknownNCT00385359Phase 4
• As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent AsthmaCompletedNCT00382889Phase 3
• Treatment of Clozapine-Induced Hypersalivation Ipratropium BromideCompletedNCT00381589Not applicable
• Short- and Long Term Growth in Children With AsthmaCompletedNCT00380484Phase 4
• Efficacy and Safety of Sinutab on Subjects in the Setting of a Common ColdCompletedNCT00378144Phase 4
• Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung DiseaseCompletedNCT00371527Not applicable
• Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In ChildrenStatus unknownNCT00371124Phase 2/3
• Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.CompletedNCT00370591Phase 4
• FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old SubjectsCompletedNCT00370097Phase 1
• Spacer Comparison In Adult AsthmaticsCompletedNCT00369993Phase 2
• An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent AsthmaCompletedNCT00365560Phase 2
• Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In AsthmaticsCompletedNCT00364442Phase 1
• Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
• SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00361959Phase 4
• Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind StudyTerminatedNCT00361452Phase 4
• Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic PatientsCompletedNCT00358488Phase 2
• Chronic Obstructive Pulmonary Disease Endpoints StudyCompletedNCT00358358Phase 4
• Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal KeratoconjunctivitisCompletedNCT00357019Phase 4
• Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
• ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.TerminatedNCT00346749Phase 4
• Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00335621Phase 4
• Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic RhinitisCompletedNCT00334698Not applicable
• Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg FormoterolCompletedNCT00327353Phase 4
• Prevention of Asthma Relapse After Discharge From EmergencyCompletedNCT00326053Phase 3
• Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic AlbuterolCompletedNCT00325767Phase 4
• Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney StoneStatus unknownNCT00323843Phase 2
• Adrenaline Injections to Children Born at Elective CSCompletedNCT00322660Not applicable
• "Death Rattle" - A Double Blind, Randomly Controlled, Crossover TrialTerminatedNCT00320892Not applicable
• Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)CompletedNCT00319488Not applicable
• Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCompletedNCT00319306Phase 3
• Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy SubjectsStatus unknownNCT00315965Phase 1
• Viapaed Study In Children And Adolescents With AsthmaCompletedNCT00315744Phase 4
• Aminophylline in Bradyasystolic Cardiac ArrestCompletedNCT00312273Phase 2
• A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDCompletedNCT00308191Phase 3
• Treatment of Persistent Wheezing in Infants and ChildrenCompletedNCT00301171Not applicable
• Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)CompletedNCT00300118Phase 3
• Theophylline in Chronic Obstructive Pulmonary DiseaseCompletedNCT00299858Phase 2/3
• Ipratropium Spray for Drooling Saliva in Parkinson's DiseaseCompletedNCT00296946Phase 2
• Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
• A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00292448Phase 2
• SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCompletedNCT00290264Phase 3
• Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised StudyCompletedNCT00289419Phase 4
• SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCompletedNCT00288379Phase 3
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
• A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPDCompletedNCT00280371Phase 3
• Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
• Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3
• Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
• Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
• A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
• Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00274508Phase 3
• SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
• Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
• Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
• Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
• Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)CompletedNCT00274027Phase 3
• Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory DisordersCompletedNCT00274014Phase 3
• Study In Asthma ControlTerminatedNCT00273026Phase 4
• The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4
• Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCompletedNCT00272753Phase 4
• Cilostazol in Acute Ischemic Stroke Treatment (CAIST)CompletedNCT00272454Phase 4
• Budesonide for Eosinophilic EsophagitisCompletedNCT00271349Phase 2
• Improving Safety of Antivenom in People Bitten by SnakesCompletedNCT00270777Phase 4
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00268216Phase 3
• A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic DisordersCompletedNCT00266578Phase 3
• Elite Sport and Development of AsthmaCompletedNCT00262587Phase 4
• Prometa Pharmacotherapy for Methamphetamine DependenceCompletedNCT00260481Phase 2/3
• SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00259792Phase 3
• Comparison Between Symbicort® and Prednisolone in COPDCompletedNCT00259779Phase 3
• SHARE - Symbicort and Health Economics in a Real Life EvaluationCompletedNCT00259766Phase 3
• Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNCT00255255Phase 3
• Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCompletedNCT00252785Phase 3
• Analysis of Atropine and Propranolol Induced ChangesCompletedNCT00251602Phase 1
• A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®CompletedNCT00244608Phase 3
• Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCompletedNCT00242775Phase 3
• A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime BedwettingCompletedNCT00240812Phase 2
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
• Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
• Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).CompletedNCT00239408Phase 4
• Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With AsthmaCompletedNCT00238927Phase 4
• SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCompletedNCT00238784Phase 3
• Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCompletedNCT00235911Phase 3
• PreAsthmaControl (PAC)CompletedNCT00234390Phase 4
• Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCompletedNCT00232648Phase 3

← Bronchodilator Agents overview